Molson Coors Beverage Company

DB:NY7 Stock Report

Market Cap: €11.8b

Molson Coors Beverage Valuation

Is NY7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NY7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NY7 (€57.56) is trading below our estimate of fair value (€174.27)

Significantly Below Fair Value: NY7 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for NY7?

Key metric: As NY7 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NY7. This is calculated by dividing NY7's market cap by their current earnings.
What is NY7's PE Ratio?
PE Ratio13.3x
EarningsUS$937.90m
Market CapUS$12.43b

Price to Earnings Ratio vs Peers

How does NY7's PE Ratio compare to its peers?

The above table shows the PE ratio for NY7 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.8x
KUL Kulmbacher Brauerei Aktien-Gesellschaft
23.5xn/a€138.4m
291 China Resources Beer (Holdings)
14.8x10.4%HK$82.9b
1876 Budweiser Brewing Company APAC
17.1x14.3%HK$95.7b
2503 Kirin Holdings Company
15.8x10.5%JP¥1.7t
NY7 Molson Coors Beverage
13.3x3.2%€12.4b

Price-To-Earnings vs Peers: NY7 is good value based on its Price-To-Earnings Ratio (13.3x) compared to the peer average (17.8x).


Price to Earnings Ratio vs Industry

How does NY7's PE Ratio compare vs other companies in the European Beverage Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
NY7 13.3xIndustry Avg. 17.3xNo. of Companies6PE01020304050+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: NY7 is good value based on its Price-To-Earnings Ratio (13.3x) compared to the European Beverage industry average (17.3x).


Price to Earnings Ratio vs Fair Ratio

What is NY7's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NY7 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.3x
Fair PE Ratio19.6x

Price-To-Earnings vs Fair Ratio: NY7 is good value based on its Price-To-Earnings Ratio (13.3x) compared to the estimated Fair Price-To-Earnings Ratio (19.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NY7 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€57.56
€58.74
+2.0%
11.8%€71.46€44.78n/a21
Nov ’25€49.76
€55.75
+12.0%
11.4%€69.47€43.54n/a20
Oct ’25€51.24
€53.93
+5.2%
11.7%€67.36€42.21n/a20
Sep ’25€47.73
€53.78
+12.7%
12.1%€67.06€42.02n/a20
Aug ’25€48.51
€55.57
+14.6%
13.6%€69.14€43.33n/a21
Jul ’25€46.82
€59.63
+27.4%
10.2%€69.86€49.36n/a22
Jun ’25€48.29
€59.68
+23.6%
9.8%€69.14€48.86n/a22
May ’25€59.02
€60.96
+3.3%
9.2%€70.15€49.57n/a22
Apr ’25€61.84
€62.48
+1.0%
6.1%€70.92€53.42n/a22
Mar ’25€57.80
€62.63
+8.4%
6.2%€71.16€53.60n/a21
Feb ’25€56.94
€62.50
+9.8%
7.0%€71.26€53.68n/a21
Jan ’25€55.02
€61.46
+11.7%
7.3%€70.53€53.13n/a21
Dec ’24€56.12
€61.16
+9.0%
7.0%€70.18€52.86n/a22
Nov ’24€54.84
€63.65
+16.1%
7.8%€72.70€53.81€49.7620
Oct ’24€58.94
€65.54
+11.2%
6.2%€72.86€53.93€51.2420
Sep ’24€58.32
€63.49
+8.9%
7.8%€71.18€49.92€47.7321
Aug ’24€63.26
€62.96
-0.5%
7.9%€68.39€49.24€48.5120
Jul ’24€59.84
€60.88
+1.7%
9.5%€69.01€49.69€46.8218
Jun ’24€57.36
€58.16
+1.4%
11.4%€68.69€45.80€48.2918
May ’24€53.48
€51.11
-4.4%
9.7%€61.63€42.60€59.0218
Apr ’24€47.13
€51.38
+9.0%
10.5%€63.43€43.84€61.8419
Mar ’24€49.07
€52.01
+6.0%
10.1%€64.10€45.25€57.8020
Feb ’24€47.91
€49.71
+3.8%
11.9%€62.81€40.96€56.9419
Jan ’24€48.03
€50.81
+5.8%
10.0%€62.71€43.06€55.0219
Dec ’23€52.31
€52.64
+0.6%
9.7%€64.84€44.52€56.1219
Nov ’23€49.17
€55.31
+12.5%
10.3%€68.84€45.56€54.8419

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies